Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Let-7b is a novel regulator of hepatitis C virus replication.

Cheng JC, Yeh YJ, Tseng CP, Hsu SD, Chang YL, Sakamoto N, Huang HD.

Cell Mol Life Sci. 2012 Aug;69(15):2621-33. doi: 10.1007/s00018-012-0940-6. Epub 2012 Mar 6.

PMID:
22391672
2.

High-throughput profiling of alpha interferon- and interleukin-28B-regulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1.

Cheng M, Si Y, Niu Y, Liu X, Li X, Zhao J, Jin Q, Yang W.

J Virol. 2013 Sep;87(17):9707-18. doi: 10.1128/JVI.00802-13. Epub 2013 Jul 3.

3.

Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome.

Takigawa Y, Nagano-Fujii M, Deng L, Hidajat R, Tanaka M, Mizuta H, Hotta H.

Microbiol Immunol. 2004;48(8):591-8.

4.

microRNA-122 target sites in the hepatitis C virus RNA NS5B coding region and 3' untranslated region: function in replication and influence of RNA secondary structure.

Gerresheim GK, Dünnes N, Nieder-Röhrmann A, Shalamova LA, Fricke M, Hofacker I, Höner Zu Siederdissen C, Marz M, Niepmann M.

Cell Mol Life Sci. 2017 Feb;74(4):747-760. doi: 10.1007/s00018-016-2377-9. Epub 2016 Sep 27.

PMID:
27677491
5.

Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication.

Wang C, Pflugheber J, Sumpter R Jr, Sodora DL, Hui D, Sen GC, Gale M Jr.

J Virol. 2003 Apr;77(7):3898-912.

6.

Novel nucleotide and amino acid covariation between the 5'UTR and the NS2/NS3 proteins of hepatitis C virus: bioinformatic and functional analyses.

Sun HY, Ou NY, Wang SW, Liu WC, Cheng TF, Shr SJ, Sun KT, Chang TT, Young KC.

PLoS One. 2011;6(9):e25530. doi: 10.1371/journal.pone.0025530. Epub 2011 Sep 28.

7.

MicroRNA let-7g cooperates with interferon/ribavirin to repress hepatitis C virus replication.

Chou WW, Huang CF, Yeh ML, Tsai YS, Hsieh MY, Huang CI, Huang JF, Tsai PC, Hsi E, Juo SH, Tsai WL, Chuang WL, Yu ML, Dai CY.

J Mol Med (Berl). 2016 Mar;94(3):311-20. doi: 10.1007/s00109-015-1348-1. Epub 2015 Oct 21.

PMID:
26489607
8.

Regulation of the hepatitis C virus genome replication by miR-199a.

Murakami Y, Aly HH, Tajima A, Inoue I, Shimotohno K.

J Hepatol. 2009 Mar;50(3):453-60. doi: 10.1016/j.jhep.2008.06.010. Epub 2008 Jul 9.

PMID:
19144437
9.

Hepatitis C virus RNA elimination and development of resistance in replicon cells treated with BMS-790052.

Wang C, Huang H, Valera L, Sun JH, O'Boyle DR 2nd, Nower PT, Jia L, Qiu D, Huang X, Altaf A, Gao M, Fridell RA.

Antimicrob Agents Chemother. 2012 Mar;56(3):1350-8. doi: 10.1128/AAC.05977-11. Epub 2012 Jan 3.

10.

Resistance analysis and characterization of NITD008 as an adenosine analog inhibitor against hepatitis C virus.

Qing J, Luo R, Wang Y, Nong J, Wu M, Shao Y, Tang R, Yu X, Yin Z, Sun Y.

Antiviral Res. 2016 Feb;126:43-54. doi: 10.1016/j.antiviral.2015.12.010. Epub 2015 Dec 24.

PMID:
26724382
11.
12.

Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodies.

Gal-Tanamy M, Zemel R, Bachmatov L, Jangra RK, Shapira A, Villanueva RA, Yi M, Lemon SM, Benhar I, Tur-Kaspa R.

Antiviral Res. 2010 Oct;88(1):95-106. doi: 10.1016/j.antiviral.2010.08.001. Epub 2010 Aug 10.

13.

Tricistronic hepatitis C virus subgenomic replicon expressing double transgenes.

Cheng X, Gao XC, Wang JP, Yang XY, Wang Y, Li BS, Kang FB, Li HJ, Nan YM, Sun DX.

World J Gastroenterol. 2014 Dec 28;20(48):18284-95. doi: 10.3748/wjg.v20.i48.18284.

15.

MicroRNA-122 antagonism against hepatitis C virus genotypes 1-6 and reduced efficacy by host RNA insertion or mutations in the HCV 5' UTR.

Li YP, Gottwein JM, Scheel TK, Jensen TB, Bukh J.

Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4991-6. doi: 10.1073/pnas.1016606108. Epub 2011 Mar 7.

16.

Sequence-specific cleavage of hepatitis C virus RNA by DNAzymes: inhibition of viral RNA translation and replication.

Roy S, Gupta N, Subramanian N, Mondal T, Banerjea AC, Das S.

J Gen Virol. 2008 Jul;89(Pt 7):1579-86. doi: 10.1099/vir.0.83650-0.

PMID:
18559927
17.

Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.

Horscroft N, Bellows D, Ansari I, Lai VC, Dempsey S, Liang D, Donis R, Zhong W, Hong Z.

J Virol. 2005 Mar;79(5):2788-96.

18.

Combinations of lambda interferon with direct-acting antiviral agents are highly efficient in suppressing hepatitis C virus replication.

Friborg J, Levine S, Chen C, Sheaffer AK, Chaniewski S, Voss S, Lemm JA, McPhee F.

Antimicrob Agents Chemother. 2013 Mar;57(3):1312-22. doi: 10.1128/AAC.02239-12. Epub 2012 Dec 28.

19.

Chemical genetics-based discovery of indole derivatives as HCV NS5B polymerase inhibitors.

Jin G, Lee S, Choi M, Son S, Kim GW, Oh JW, Lee C, Lee K.

Eur J Med Chem. 2014 Mar 21;75:413-25. doi: 10.1016/j.ejmech.2014.01.062. Epub 2014 Jan 31.

PMID:
24561671
20.

Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus.

Jiang D, Guo H, Xu C, Chang J, Gu B, Wang L, Block TM, Guo JT.

J Virol. 2008 Feb;82(4):1665-78. Epub 2007 Dec 12.

Supplemental Content

Support Center